Luma Vision announced that it completed 15 AFib ablation procedures as part of a clinical study in collaboration with CardioFocus.

LUMA Vision Ltd., a leader in cardiac 4D navigation and imaging, today announced the successful completion of 15 VERAFEYE™-guided persistent atrial fibrillation (AF) ablation procedures conducted as ...

LUMA Vision Ltd., a leader in cardiac 4D navigation and imaging, today announced the successful completion of 15 VERAFEYEtm-guided persistent atrial fibrillation (AF) ablation procedures conducted as ...

After approval in late 2024, Johnson & Johnson's Varipulse PFA system started 2025 on the wrong foot: Its early rollout had ...

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today ...

It feels like there’s always something new popping up in medicine, and cardiac ablation is no different. Boston Scientific has a new system called FARAPULSE that’s getting a lot of attention. It uses ...

Farapulse has propelled Boston Scientific’s electrophysiology business to triple-digit growth, exceeding the company’s expectations, since the device won FDA approval in early 2024 for people whose ...

Background: The achievement of first-pass isolation (FPI) during pulmonary vein isolation (PVI) generally serves as a reliable marker of lesion quality in initial radiofrequency encirclement and ...

Northwell Lenox Hill Hospital (LHH) and Staten Island University Hospital (SIUH) were among the first in the country to successfully treat persistent atrial fibrillation (AFib) and typical atrial ...